261373-04-0 Usage
Uses
Used in Organic Synthesis:
2,3-Dibromo-6-picoline is used as a building block in organic synthesis for its ability to facilitate the creation of various complex organic molecules. Its unique structure with bromine atoms allows for versatile chemical reactions, making it a valuable component in the synthesis of a wide range of compounds.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 2,3-dibromo-6-picoline serves as a useful intermediate. Its presence in the synthesis process contributes to the development of new drugs, potentially enhancing the therapeutic options available for various medical conditions.
Used in Agrochemical Production:
Similarly, in the agrochemical sector, 2,3-dibromo-6-picoline is utilized as an intermediate. Its role in the synthesis of agrochemicals is crucial for the development of effective products aimed at improving crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 261373-04-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,3,7 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 261373-04:
(8*2)+(7*6)+(6*1)+(5*3)+(4*7)+(3*3)+(2*0)+(1*4)=120
120 % 10 = 0
So 261373-04-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H5Br2N/c1-4-2-3-5(7)6(8)9-4/h2-3H,1H3
261373-04-0Relevant articles and documents
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
-
Page column 146, (2010/02/07)
Pharmaceutical compositions containing an FBPase inhibitor and an insulin sensitizer are provided as well as methods for treating diabetes and diseases responding to increased glycemic control, an improvement in insulin sensitivity, a reduction in insulin levels, or an enhancement of insulin secretion.
Novel bisamidate phosphonate prodrugs
-
, (2008/06/13)
Novel bisamidate phosphonate prodrugs of FBPase inhibitors of the Formula IA: and their use in the treatment of diabetes and other conditions associated with elevated blood glucose.
Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase
-
, (2008/06/13)
FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
